APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025180 pages

Choose your research edition.

Industry ResearchDiphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine include Walvax Biotechnology, Sanofi, GSK, Sinopharm, Serum Institute of India and KM Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Segment by Company

Walvax Biotechnology

Sanofi

GSK

Sinopharm

Serum Institute of India

KM Biologics

Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Segment by Type

DTaP

Tdap

Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Segment by Application

Child

Adult

Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Trends Table 2. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Drivers Table 3. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Opportunities and Challenges Table 4. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Restraints Table 5. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Manufacturers Table 9. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Manufacturers, Product Type & Application Table 13. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of DTaP Table 17. Major Manufacturers of Tdap Table 18. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Child Table 29. Major Manufacturers of Adult Table 30. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2021-2026) & (k units) Table 32. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2027-2032) & (k units) Table 33. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2021-2026) & (k units) Table 37. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2027-2032) & (k units) Table 38. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2021-2026) & (k units) Table 42. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2021-2026) & (k units) Table 47. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2027-2032) & (k units) Table 48. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2021-2026) & (k units) Table 50. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2027-2032) & (k units) Table 57. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Region (2027-2032) Table 62. Walvax Biotechnology Company Information Table 63. Walvax Biotechnology Business Overview Table 64. Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio Table 66. Walvax Biotechnology Recent Development Table 67. Sanofi Company Information Table 68. Sanofi Business Overview Table 69. Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio Table 71. Sanofi Recent Development Table 72. GSK Company Information Table 73. GSK Business Overview Table 74. GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio Table 76. GSK Recent Development Table 77. Sinopharm Company Information Table 78. Sinopharm Business Overview Table 79. Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio Table 81. Sinopharm Recent Development Table 82. Serum Institute of India Company Information Table 83. Serum Institute of India Business Overview Table 84. Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio Table 86. Serum Institute of India Recent Development Table 87. KM Biologics Company Information Table 88. KM Biologics Business Overview Table 89. KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio Table 91. KM Biologics Recent Development Table 92. Key Raw Materials Table 93. Raw Materials Key Suppliers Table 94. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Distributors List Table 95. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Customers List Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Image Figure 2. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (2021-2032) & (k units) Figure 5. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. DTaP Image Figure 9. Tdap Image Figure 10. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Child Image Figure 17. Adult Image Figure 18. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • DTaP
  • Tdap
Applications
  • Child
  • Adult
Companies covered
  • Walvax Biotechnology
  • Sanofi
  • GSK
  • Sinopharm
  • Serum Institute of India
  • KM Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Dynamics
  1. 2.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Trends
  2. 2.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Drivers
  3. 2.3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Opportunities and Challenges
  4. 2.4 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Restraints
3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market by Manufacturers
  1. 3.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Tier 1, Tier 2, and Tier 3
4 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market by Type
  1. 4.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Type Introduction
  2. 4.1.1 DTaP
  3. 4.1.2 Tdap
  4. 4.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type
  5. 4.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type
  9. 4.3.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Type (2021-2032)
5 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market by Application
  1. 5.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Application Introduction
  2. 5.1.1 Child
  3. 5.1.2 Adult
  4. 5.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application
  5. 5.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application
  9. 5.3.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Application (2021-2032)
6 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region
  1. 6.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region
  1. 7.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region
  2. 7.1.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Walvax Biotechnology
  2. 8.1.1 Walvax Biotechnology Company Information
  3. 8.1.2 Walvax Biotechnology Business Overview
  4. 8.1.3 Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio
  6. 8.1.5 Walvax Biotechnology Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 Sinopharm
  20. 8.4.1 Sinopharm Company Information
  21. 8.4.2 Sinopharm Business Overview
  22. 8.4.3 Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio
  24. 8.4.5 Sinopharm Recent Developments
  25. 8.5 Serum Institute of India
  26. 8.5.1 Serum Institute of India Company Information
  27. 8.5.2 Serum Institute of India Business Overview
  28. 8.5.3 Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio
  30. 8.5.5 Serum Institute of India Recent Developments
  31. 8.6 KM Biologics
  32. 8.6.1 KM Biologics Company Information
  33. 8.6.2 KM Biologics Business Overview
  34. 8.6.3 KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Portfolio
  36. 8.6.5 KM Biologics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Value Chain Analysis
  2. 9.1.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Production Mode & Process
  6. 9.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Distributors
  9. 9.2.3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst